Tumour cells are sensitised to ferroptosis via RB1CC1‐mediated transcriptional reprogramming
Clinical and Translational Medicine2022Vol. 12(2), pp. e747–e747
Citations Over TimeTop 10% of 2022 papers
Xiangfei Xue, Lifang Ma, Xiao Zhang, Xin Xu, Susu Guo, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Wanxin Guo, Yongchun Yu, Fenyong Sun, Yi Shi, Jiayi Wang
Abstract
Our findings indicate that RB1CC1-associated signalling sensitises tumour cells to ferroptosis and that targeting RB1CC1 may be beneficial for tumour treatment.
Related Papers
- → Biophysical regulation of cell reprogramming(2017)34 cited
- → Direct reprogramming 101(2010)20 cited
- → Advances in Reprogramming to Pluripotency(2015)8 cited
- → Chemicals Facilitating Reprogramming(2014)
- Progresses on Mechanisms on Reprogramming of Somatic Cells in Mammals(2013)